Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

The pangenotypic regimen of glecaprevir and pibrentasvir (G/P) is approved to treat adults with chronic hepatitis C virus (HCV) infection and has yielded high cure rates in adults in clinical trials. Approved treatment options for pediatrics may include ribavirin. A pangenotypic regimen for pediatri...

詳細記述

保存先:
書誌詳細
出版年:Hepatology
主要な著者: Jonas, Maureen M., Squires, Robert H., Rhee, Susan M., Lin, Chih‐Wei, Bessho, Kazuhiko, Feiterna‐Sperling, Cornelia, Hierro, Loreto, Kelly, Deirdre, Ling, Simon C., Strokova, Tatiana, del Valle‐Segarra, Antonio, Lovell, Sandra, Liu, Wei, Ng, Teresa I., Porcalla, Ariel, Gonzalez, Yuri Sanchez, Burroughs, Margaret, Sokal, Etienne
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2019
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028097/
https://ncbi.nlm.nih.gov/pubmed/31254392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30840
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料